Small primary intracerebral hemorrhage. Clinical presentation of 28 cases.
نویسندگان
چکیده
منابع مشابه
Small Primary Intracerebral Hemorrhage
Background Although there have been sporadic reports of patients with small intracerebral hemorrhages presenting with discrete clinical features, the clinical and distributional characteristics of these hemorrhages have not been adequately investigated. Case Descriptions We studied 28 patients who had primary intracerebral hemorrhage of a longest diameter s l .5 cm as seen in computed tomograph...
متن کاملCADASIL: two new cases with intracerebral hemorrhage
Whether cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a risk factor for spontaneous intracerebral hemorrhage (ICH) and influences outcomes remains unclear. In this study, we report two cases of CADASIL presenting with cerebral hemorrhages. These cases suggest that a CADASIL vasculopathy by itself mainly results in ICH, as indicated by sl...
متن کاملLeakage Sign for Primary Intracerebral Hemorrhage
Supplemental Table I. Hounsfield units in the region of interest in patients with primary intracerebral hematoma, based on the presence of the spot sign and leakage sign Hounsfield units (mean ± standard deviation) P (ANOVA) P (Student's t-test)
متن کاملContrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases.
BACKGROUND AND PURPOSE Several retrospective studies suggested that contrast extravasation on CT angiography predicts hematoma expansion, poor outcome, and mortality in primary intracerebral hemorrhage. We aimed to determine the predictive value of contrast extravasation on multidetector CT angiography for clinical outcome in a prospective study. METHODS In 160 consecutive patients with spont...
متن کاملOngoing clinical trials in intracerebral hemorrhage.
ntracerebral hemorrhage (ICH) accounts for 10% to 15% of all strokes. ICH continues to impart a considerable degree of morbidity and mortality, with 30-day mortality ranging from 44% to 50%. ICH remains a devastating disease, and current treatment options lag far behind those for ischemic stroke. There are no approved therapies, which improve outcome, and treatment remains mainly supportive. De...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 1994
ISSN: 0039-2499,1524-4628
DOI: 10.1161/01.str.25.7.1500